DR. Jonathan Cohen
MD, PHD (MEDICINE), DIRECTOR OF CLINICAL RESEARCH AT THE SHARETT INSTITUTE OF ONCOLOGY OF THE HADASSAH UNIVERSITY HOSPITAL
Specialization
Oncology:
- melanoma;
- state-of-the-art immunotherapeutic agents for the treatment of melanoma and gastrointestinal tumors;
- TIL-therapy.
Experience 12 years
Education
- 2009 — Graduated from the Medical School of Ben Gurion University (Beersheba, Israel)
- 2010 — Obtained a PhD in neurosciences at Ben Gurion University
Career history
- 2008–2009 — Internship at the Barzilai Medical Center (Ashkelon, Israel)
- 2010–2015 — Specialization in oncology at the Hadassah University Hospital (Jerusalem, Israel)
- Since 2014 — Scientific Advisor in Pepticom LTD, Israeli pharmaceutical company developing state-of-the-art anticancer peptides
- Since 2015 — Senior expert at the Department of Oncology at the Hadassah University Hospital
- Since 2020 — Director of Clinical Research at the Sharett Institute of Oncology of the Hadassah University Hospital
Participation in associations:
- Israeli Society for Clinical Oncology
- International Society for Clinical Oncology
Language proficiency
English, Hebrew
